FindTrial
Sign In

A clinical trial to study the two supraglotic airway device Baska and Blockbuster LMA in patients undergoing laprascopic cholecystectomy surgery

Comparative Evaluation Of Baska Mask And Blockbuster Lma For Airway Management During Laparoscopic Cholecystectomy- A Prospective Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059364
Enrollment
120
Registered
2023-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K812- Acute cholecystitis with chronic cholecystitis

Interventions

Intervention1: baskamask: ease of insertion number of attempt hemodynamic changes in laprascopic cholecystectomy for 6 month Control Intervention1: blockbuster lma: /compare the above two for hemodyna

Sponsors

MLB MEDICAL COLLEGE JHANSI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 Men and women Aged 18 to 60 years Procedure time 30 to 120 min undergoing elective laparoscopic cholecystectomy procedures under general anaesthesia

Exclusion criteria

Exclusion criteria: ASA 3 and 4 Difficult airway mallampati 3 and 4 Decreased lung compliance increased risk of aspiration Emergency cases Bleeding or coagulation disorder Head and neck oral surgery Age 60 years Obese, BMI more than 28 kg per meter square Patient refusal

Design outcomes

Primary

MeasureTime frame
•hemodynamic changesTimepoint: •60 min—

Secondary

MeasureTime frame
• number of attempts • time for insertion • ease of insertion • adequacy of ventilation • complications Timepoint: 60 min—

Countries

India

Contacts

Public ContactDR ROOPESH KUMAR

MLB MEDICAL COLLEGE

SHUBAM007ACHARI@GMAIL.COM8123359024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026